$1.34 Billion is the total value of Antipodean Advisors LLC's 21 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 46.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LNG | Sell | CHENIERE ENERGY INC | $172,725,000 | +24.4% | 2,409,000 | -4.0% | 12.90% | -0.4% |
STZ | Sell | CONSTELLATION BRANDS INCcl a | $104,346,000 | -12.3% | 1,184,000 | -15.4% | 7.80% | -29.8% |
ENDP | Sell | ENDO INTL PLC | $73,941,000 | -3.0% | 1,056,000 | -4.9% | 5.52% | -22.3% |
ILMN | Sell | ILLUMINA INC | $73,469,000 | +14.6% | 411,500 | -4.6% | 5.49% | -8.3% |
HRB | Sell | BLOCK H & R INC | $37,082,000 | -33.4% | 1,106,273 | -40.0% | 2.77% | -46.7% |
NRF | Sell | NORTHSTAR RLTY FIN CORP | $30,172,000 | -54.6% | 1,736,000 | -57.9% | 2.25% | -63.7% |
SHLDQ | Sell | SEARS HLDGS CORP | $5,275,000 | -61.2% | 132,000 | -53.7% | 0.39% | -69.0% |
UNIS | Exit | UNILIFE CORP NEW | $0 | – | -1,784,000 | -100.0% | -0.68% | – |
BOFI | Exit | BOFI HLDG INC | $0 | – | -140,000 | -100.0% | -1.12% | – |
ZU | Exit | ZULILY INCcl a | $0 | – | -366,383 | -100.0% | -1.72% | – |
CBS | Exit | CBS CORP NEWcl b | $0 | – | -394,000 | -100.0% | -2.27% | – |
JCPNQ | Exit | PENNEY J C INC | $0 | – | -3,171,000 | -100.0% | -2.55% | – |
LNKD | Exit | LINKEDIN CORP | $0 | – | -345,400 | -100.0% | -5.96% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CARVANA CO | 21 | Q2 2023 | 38.5% |
AMAZON COM INC | 20 | Q4 2020 | 33.8% |
SEA LTD | 19 | Q3 2023 | 60.8% |
CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
MEDICINES CO | 18 | Q4 2019 | 19.8% |
ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.